Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

The review highlights the importance of stem cells in hair health and suggests new treatment strategies for hair loss conditions.

PHAT may improve hair growth better than PRP alone.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

The document concludes that there are various causes and treatments for hair loss, with hair transplantation being a notable option.

N793 may improve hair density in people with mild hair thinning.

Both low-level light therapy and 5% minoxidil are effective and safe for treating male hair loss, with no significant difference in results.

Midscalp hair density and terminal hair percentage are good indicators of female pattern hair loss severity.

The document concludes that personalized treatment plans for hair loss in Asian men are necessary and more research is needed to develop effective guidelines.

Patients with androgenetic alopecia have thinner subcutaneous fat layers in their frontal scalp compared to healthy individuals.

Women with androgenetic alopecia have lower zinc and iron levels.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Smoking and alcohol worsen hair transplant results.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

The new system helps detect and track early female hair loss better.

Different factors help diagnose and treat hair loss accurately.

The BASP classification is effective for diagnosing pattern hair loss in Indian men and women.

The modified hair loss classification is more detailed but less user-friendly.

The authors suggest using a standard system to name hair grafts to improve communication in hair restoration.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

The review suggests limited treatments for common hair loss conditions, with potential for future improvements.

Using 3% topical minoxidil can help women with hair loss, but more research is needed.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

AGA increased yearly, type I most common, and family history and seborrheic dermatitis often linked.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

Hair loss reduces hair thickness and coverage, but drug treatments mainly revive dormant hairs rather than reverse thinning; patients often undervalue their hair loss severity.